p53 regulates Btk-dependent B cell proliferation but not differentiation

Journal of Leukocyte Biology

Volumn 79, Issue 4, 2006, Pages 852-859

  Schmidt, Nathan W ^a   Mayo, Lindsey D ^b   Donner, David B ^a   Kaplan, Mark H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

B lymphocyte; Development; Immunoglobulin; Tumor suppressor

Indexed keywords

BRUTON TYROSINE KINASE; IMMUNOGLOBULIN M; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PROTEIN P53; AGAMMAGLOBULINAEMIA TYROSINE KINASE; MITOGENIC AGENT; PROTEIN TYROSINE KINASE;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; ANIMAL; BONE MARROW CELL; CELL COUNT; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY; SPLEEN;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; IMMUNOLOGIC TESTS; MICE; MICE, KNOCKOUT; MITOGENS; PROTEIN-TYROSINE KINASES; SPLEEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746425865     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0705402     Document Type: Article

References (34)

1. Yang, W. C., Collette, Y., Nunes, J. A., Olive, D. (2000) Tec kinases: a family with multiple roles in immunity. Immunity 12, 373-382.
2. Tsukada, S., Baba, Y., Watanabe, D. (2001) Btk and BLNK in B cell development. Adv. Immunol. 77, 123-162.
3. Satterthwaite, A. B., Li, Z., Witte, O. N. (1998) Btk function in B cell development and response. Semin. Immunol. 10, 309-316.
4. Tarakhovsky, A. (1997) Xid- and Xid-like immunodeficiencies from a signaling point of view. Curr. Opin. Immunol. 9, 319-323.
5. Fu, C., Turck, C. W., Kurosaki, T., Chan, A. C. (1998) BLNK: a central linker protein in B cell activation. Immunity 9, 93-103.
6. Kurosaki, T., Tsukada, S. (2000) BLNK: connecting Syk and Btk to calcium signals. Immunity 12, 1-5.
7. Wahl, M. I., Fluckiger, A. C., Kato, R. M., Park, H., Witte, O. N., Rawlings, D. J. (1997) Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc. Natl. Acad. Sci. USA 94, 11526-11533.
8. Hata, D., Kawakami, Y., Inagaki, N., Lantz, C. S., Kitamura, T., Khan, W. N., Maeda-Yamamoto, M., Miura, T., Han, W., Hartman, S. E., Yao, L., Nagai, H., Goldfeld, A. E., Alt, F. W., Galli, S. J., Witte, O. N., Kawakami, T. (1998) Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulation and cytokine production. J. Exp. Med. 187, 1235-1247.
9. Campbell, K. S. (1999) Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol. 11, 256-264.
10. Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., et al. (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X- linked agammaglobulinemia. Cell 72, 279-290.
11. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L., Kinnon, C., Levinsky, R., Bobrow, M., et al. (1993) The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226-233.
12. Scher, I. (1982) The CBA/N mouse strain: an experimental model illustrating the influence of X chromosome on immunity. Adv. Immunol. 33, 1-71.
13. Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G., Davidson, L., Muller, S., Kantor, A. B., Herzenberg, L. A., et al. (1995) Defective B cell development and function in Btk-deficient mice. Immunity 3, 283-299.
14. Woodland, R. T., Schmidt, M. R., Korsmeyer, S. J., Gravel, K. A. (1996) Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J. Immunol. 156, 2143-2154.
15. Solvason, N., Wu, W. W., Kabra, N., Lund-Johansen, F., Roncarolo, M. G., Behrens, T. W., Grillot, D. A., Nunez, G., Lees, E., Howard, M. (1998) Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187, 1081-1091.
16. Ryan, K. M., Phillips, A. C., Vousden, K. H. (2001) Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337.
17. Bates, S., Vousden, K. H. (1999) Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55, 28-37.
18. Mayo, L. D., Donner, D. B. (2001) A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 98, 11598-11603.
19. Balint, E. E., Vousden, K. H. (2001) Activation and activities of the p53 tumor suppressor protein. Br. J. Cancer 85, 1813-1823.
20. Miyashita, T., Harigai, M., Hanada, M., Reed, J. C. (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54, 3131-3135.
21. Sugars, K. L., Budhram-Mahadeo, V., Packham, G., Latchman, D. S. (2001) A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res. 29, 4530-4540.
22. Salleh, M. N., Caldwell, J., Carmichael, P. L. (2003) A comparison of gene expression changes in response to diethylstilbestrol treatment in wild-type and p53+/- hemizygous knockout mice using focused arrays. Toxicology 185, 49-57.
23. Salleh, M. N., Ismail, P., Abdullah, A. S., Taufiq-Yap, Y. H., Carmichael, P. (2004) Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration. IUBMB Life 56, 409-416.
24. Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., El-Deiry, W. S. (2002) BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 4, 842-849.
25. Lu, L., Lejtenyi, D., Osmond, D. G. (1999) Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro-B cells in P53-deficient mouse bone marrow. Eur. J. Immunol. 29, 2484-2490.
26. Shick, L., Carman, J. H., Choi, J. K., Somasundaram, K., Burrell, M., Hill, D. E., Zeng, Y. X., Wang, Y., Wiman, K. G., Salhany, K., Kadesch, T. R., Monroe, J. G., Donehower, L. A., el-Deiry, W. S. (1997) Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice. Cell Growth Differ. 8, 121-131.
27. Mendrysa, S. M., McElwee, M. K., Michalowski, J., O'Leary, K. A., Young, K. M., Perry, M. E. (2003) mdm2 is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Mol. Cell. Biol. 23, 462-472.
28. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., Weinberg, R. A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
29. Dillon, S. R., Constantinescu, A., Schlissel, M. S. (2001) Annexin V binds to positively selected B cells. J. Immunol. 166, 58-71.
30. Niiro, H., Clark, E. A. (2002) Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2, 945-956.
31. Anderson, J. S., Teutsch, M., Dong, Z., Wortis, H. H. (1996) An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93, 10966-10971.
32. Brorson, K., Brunswick, M., Ezhevsky, S., Wei, D. G., Berg, R., Scott, D., Stein, K. E. (1997) xid affects events leading to B cell cycle entry. J. Immunol. 159, 135-143.
33. Middendorp, S., Dingjan, G. M., Hendriks, R. W. (2002) Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice. J. Immunol. 168, 2695-2703.
34. Klaus, G. G., Holman, M., Johnson-Leger, C., Elgueta-Karstegl, C., Atkins, C. (1997) A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Eur. J. Immunol. 27, 2749-2756.